Huntington's disease (HD) is characterized by brain atrophy. Localized atrophy of a specific structure could potentially be a more sensitive biomarker reflecting neuropathologic changes rather than global volume variation. We examined 90 TRACK-HD participants of which 30 were premanifest HD, 30 were manifest HD and 30 were controls. Using FMRIB's Integrated Registration and Segmentation Tool, segmentations were obtained for the pallidum, caudate nucleus, putamen, thalamus, accumbens nucleus, amygdala, and hippocampus and overall volumes were calculated. A point distribution model of each structure was obtained using Growing and Adaptive Meshes. Permutation testing between groups was performed to detect local displacement in shape between gr...
Abstract Numerous neuroimaging techniques have been used to identify biomarkers of disease progressi...
TRACK-HD is a multicentre longitudinal observational study investigating the use of clinical assessm...
Background: The neuropathological hallmark of Huntington's disease (HD) is progressive striatal loss...
AbstractHuntington's disease (HD) is characterized by brain atrophy. Localized atrophy of a specific...
Huntington disease (HD) is a neurodegenerative disorder that involves preferential atrophy in the st...
Huntington disease (HD) is a neurodegenerative disorder that involves preferential atrophy in the st...
In Huntington's disease (HD) atrophy of the caudate nucleus and putamen has been described many year...
Huntington’s disease (HD) involves preferential and progressive degeneration of striatum and other s...
In patients with premotor Huntington's disease (pmHD), literature has reported decreases in caudate ...
The striatum has traditionally been the focus of Huntington's disease research due to the prima...
In Huntington's disease (HD), neurodegeneration causes progressive atrophy to the striatum, cortical...
We aimed to investigate the relationship between striatal morphology in Huntington disease (HD) and ...
Huntington disease (HD) is a fatal progressive neurodegenerative disorder for which only symptomatic...
Background and ObjectivesLongitudinal measurements of brain atrophy using structural MRI (sMRI) can ...
Background The discovery of potential disease-modifying therapies in a neurodegenerative condition l...
Abstract Numerous neuroimaging techniques have been used to identify biomarkers of disease progressi...
TRACK-HD is a multicentre longitudinal observational study investigating the use of clinical assessm...
Background: The neuropathological hallmark of Huntington's disease (HD) is progressive striatal loss...
AbstractHuntington's disease (HD) is characterized by brain atrophy. Localized atrophy of a specific...
Huntington disease (HD) is a neurodegenerative disorder that involves preferential atrophy in the st...
Huntington disease (HD) is a neurodegenerative disorder that involves preferential atrophy in the st...
In Huntington's disease (HD) atrophy of the caudate nucleus and putamen has been described many year...
Huntington’s disease (HD) involves preferential and progressive degeneration of striatum and other s...
In patients with premotor Huntington's disease (pmHD), literature has reported decreases in caudate ...
The striatum has traditionally been the focus of Huntington's disease research due to the prima...
In Huntington's disease (HD), neurodegeneration causes progressive atrophy to the striatum, cortical...
We aimed to investigate the relationship between striatal morphology in Huntington disease (HD) and ...
Huntington disease (HD) is a fatal progressive neurodegenerative disorder for which only symptomatic...
Background and ObjectivesLongitudinal measurements of brain atrophy using structural MRI (sMRI) can ...
Background The discovery of potential disease-modifying therapies in a neurodegenerative condition l...
Abstract Numerous neuroimaging techniques have been used to identify biomarkers of disease progressi...
TRACK-HD is a multicentre longitudinal observational study investigating the use of clinical assessm...
Background: The neuropathological hallmark of Huntington's disease (HD) is progressive striatal loss...